The removal of warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms is a major turnaround that's likely to encourage more women to seek treatment. Dr. Cindy Long, OBGYN from HCA HealthONE Women's Health Group, visits with CBS News Colorado about the announcement.
FDA no longer requiring significant warning label with hormone therapies for menopause
The U.S. Food and Drug Administration will remove the "black box" warning labels on menopause therapies.